Updated on 2024/04/27

写真a

 
YOSHIMATSU Yasuhiro
 
Organization
Academic Assembly Institute of Medicine and Dentistry IGAKU KEIRETU Associate Professor
Graduate School of Medical and Dental Sciences Molecular and Cellular Medicine Signal Transduction Research Associate Professor
Title
Associate Professor
External link

Degree

  • 博士(医学) ( 2010.3 )

  • 修士(農学) ( 2001.3 )

Research Interests

  • endothelial-mesenchymal transition (EndoMT)

  • angiogenesis

  • lymphangiogenesis

  • TGF-β family

  • blood vessel

  • BMP

  • lymphatic vessel

  • cancer biology

  • lymphedema

  • endothelial homeostasis

Research Areas

  • Life Science / Molecular biology

  • Life Science / Applied biochemistry

  • Life Science / Cell biology

  • Life Science / Medical biochemistry

Research History

  • Niigata University   Graduate School of Medical and Dental Sciences Molecular and Cellular Medicine Signal Transduction Research   Associate Professor

    2019.5

Education

  • The University of Tokyo   Graduate School of Medicine   病因・病理学専攻

    2006.4 - 2010.3

      More details

  • The University of Tokyo   Graduate School of Agriculture and Life Sciences   Department of Biotechnology

    1999.4 - 2001.3

      More details

  • The University of Tokyo   Faculty of Agriculture

    1995.4 - 1999.3

      More details

    Country: Japan

    researchmap

Committee Memberships

  • Japanese Society of Lymphology   academic councilor  

    2021.1   

      More details

    Committee type:Academic society

    researchmap

  • Japanese Cancer Association   academic councilor  

    2020.1   

      More details

    Committee type:Academic society

    researchmap

  • Japanese Vascular Biology and Medicine Organization   academic councilor  

    2014.4   

      More details

    Committee type:Academic society

    researchmap

 

Papers

  • Vasohibin-2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling Reviewed

    Rie Norita, Yasuhiro Suzuki, Yutaka Furutani, Kazuki Takahashi, Yasuhiro Yoshimatsu, Katarzyna A. Podyma-Inoue, Tetsuro Watabe, Yasufumi Sato

    Cancer Science   108 ( 3 )   419 - 426   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Blackwell Publishing Ltd  

    Vasohibin-2 (VASH2) is a homolog of VASH1, an endothelium-derived angiogenesis inhibitor. Vasohibin-2 is mainly expressed in cancer cells, and has been implicated in the progression of cancer by inducing angiogenesis and tumor growth. Although VASH2 has been recently reported to be involved in epithelial–mesenchymal transition (EMT), its precise roles are obscure. The aim of the present study was to clarify the role of VASH2 in the EMT of cancer cells in relation to transforming growth factor-β (TGF-β) signaling, which is a major stimulator of EMT. Decreased expression of VASH2 in ovarian cancer cells significantly repressed the expression of TGF-β type I receptor, namely activin receptor-like kinase 5. Transforming growth factor-β1-induced phosphorylation of Smad2 and Smad3 was markedly decreased in VASH2 knockdown cells while the expression of Smad2 and Smad3 was unchanged. Accordingly, the responses to TGF-β1 shown by promoter assay and plasminogen activator inhibitor type 1 expression were significantly attenuated in VASH2 knockdown cells. Furthermore, knockdown of VASH2 in cancer cells abrogated the TGF-β1-induced reduced expression of epithelial markers including E-cadherin, and the elevated expression of mesenchymal markers including fibronectin, ZEB2, and Snail2, suggesting that endogenous VASH2 is required for TGF-β1-induced EMT. In accordance with these results, the effects of TGF-β1 on cell morphology, migration, invasion, and MMP2 expression were also abrogated when VASH2 was knocked down. These results indicate that VASH2 played a significant role in the EMT by modulating the TGF-β signaling. We propose that VASH2 would be a novel molecular target for the prevention of EMT in cancers.

    DOI: 10.1111/cas.13157

    Scopus

    PubMed

    researchmap

  • Reduced chondroitin sulfate content prevents diabetic neuropathy through transforming growth factor-β signaling suppression. International journal

    Hajime Ishiguro, Takashi Ushiki, Atsuko Honda, Yasuhiro Yoshimatsu, Riuko Ohashi, Shujiro Okuda, Asami Kawasaki, Kaori Cho, Suguru Tamura, Tatsuya Suwabe, Takayuki Katagiri, Yiwei Ling, Atsuhiko Iijima, Tadahisa Mikami, Hiroshi Kitagawa, Akiyoshi Uemura, Kazunori Sango, Masayoshi Masuko, Michihiro Igarashi, Hirohito Sone

    iScience   27 ( 4 )   109528 - 109528   2024.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Diabetic neuropathy (DN) is a major complication of diabetes mellitus. Chondroitin sulfate (CS) is one of the most important extracellular matrix components and is known to interact with various diffusible factors; however, its role in DN pathology has not been examined. Therefore, we generated CSGalNAc-T1 knockout (T1KO) mice, in which CS levels were reduced. We demonstrated that diabetic T1KO mice were much more resistant to DN than diabetic wild-type (WT) mice. We also found that interactions between pericytes and vascular endothelial cells were more stable in T1KO mice. Among the RNA-seq results, we focused on the transforming growth factor β signaling pathway and found that the phosphorylation of Smad2/3 was less upregulated in T1KO mice than in WT mice under hyperglycemic conditions. Taken together, a reduction in CS level attenuates DN progression, indicating that CS is an important factor in DN pathogenesis.

    DOI: 10.1016/j.isci.2024.109528

    PubMed

    researchmap

  • A MAP1B-cortactin-Tks5 axis regulates TNBC invasion and tumorigenesis. International journal

    Hiroki Inoue, Taku Kanda, Gakuto Hayashi, Ryota Munenaga, Masayuki Yoshida, Kana Hasegawa, Takuya Miyagawa, Yukiya Kurumada, Jumpei Hasegawa, Tomoyuki Wada, Motoi Horiuchi, Yasuhiro Yoshimatsu, Fumiko Itoh, Yuki Maemoto, Kohei Arasaki, Yuichi Wakana, Tetsuro Watabe, Hiromichi Matsushita, Hironori Harada, Mitsuo Tagaya

    The Journal of cell biology   223 ( 3 )   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The microtubule-associated protein MAP1B has been implicated in axonal growth and brain development. We found that MAP1B is highly expressed in the most aggressive and deadliest breast cancer subtype, triple-negative breast cancer (TNBC), but not in other subtypes. Expression of MAP1B was found to be highly correlated with poor prognosis. Depletion of MAP1B in TNBC cells impairs cell migration and invasion concomitant with a defect in tumorigenesis. We found that MAP1B interacts with key components for invadopodia formation, cortactin, and Tks5, the latter of which is a PtdIns(3,4)P2-binding and scaffold protein that localizes to invadopodia. We also found that Tks5 associates with microtubules and supports the association between MAP1B and α-tubulin. In accordance with their interaction, depletion of MAP1B leads to Tks5 destabilization, leading to its degradation via the autophagic pathway. Collectively, these findings suggest that MAP1B is a convergence point of the cytoskeleton to promote malignancy in TNBC and thereby a potential diagnostic and therapeutic target for TNBC.

    DOI: 10.1083/jcb.202303102

    PubMed

    researchmap

  • CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial–mesenchymal transition in tumor microenvironment International journal

    Kazuki Takahashi, Miho Kobayashi, Hisae Katsumata, Shiori Tokizaki, Tatsuhiko Anzai, Yukinori Ikeda, Daniel M. Alcaide, Kentaro Maeda, Makoto Ishihara, Katsutoshi Tahara, Yoshiaki Kubota, Fumiko Itoh, Jihwan Park, Kunihiko Takahashi, Yukiko T. Matsunaga, Yasuhiro Yoshimatsu, Katarzyna A. Podyma‐Inoue, Tetsuro Watabe

    Cancer Science   115 ( 2 )   490 - 506   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    Tumor progression and metastasis are regulated by endothelial cells undergoing endothelial–mesenchymal transition (EndoMT), a cellular differentiation process in which endothelial cells lose their properties and differentiate into mesenchymal cells. The cells undergoing EndoMT differentiate through a spectrum of intermediate phases, suggesting that some cells remain in a partial EndoMT state and exhibit an endothelial/mesenchymal phenotype. However, detailed analysis of partial EndoMT has been hampered by the lack of specific markers. Transforming growth factor‐β (TGF‐β) plays a central role in the induction of EndoMT. Here, we showed that inhibition of TGF‐β signaling suppressed EndoMT in a human oral cancer cell xenograft mouse model. By using genetic labeling of endothelial cell lineage, we also established a novel EndoMT reporter cell system, the EndoMT reporter endothelial cells (EMRECs), which allow visualization of sequential changes during TGF‐β‐induced EndoMT. Using EMRECs, we characterized the gene profiles of multiple EndoMT stages and identified CD40 as a novel partial EndoMT‐specific marker. CD40 expression was upregulated in the cells undergoing partial EndoMT, but decreased in the full EndoMT cells. Furthermore, single‐cell RNA sequencing analysis of human tumors revealed that CD40 expression was enriched in the population of cells expressing both endothelial and mesenchymal cell markers. Moreover, decreased expression of CD40 in EMRECs enhanced TGF‐β‐induced EndoMT, suggesting that CD40 expressed during partial EndoMT inhibits transition to full EndoMT. The present findings provide a better understanding of the mechanisms underlying TGF‐β‐induced EndoMT and will facilitate the development of novel therapeutic strategies targeting EndoMT‐driven cancer progression and metastasis.

    DOI: 10.1111/cas.16045

    PubMed

    researchmap

  • TGF-βによる内皮間葉移行(EndoMT)の段階的遷移をEndoMTレポーター内皮細胞は可視化した(Endothelial mesenchymal transition(EndoMT) reporter cells visualized stepwise transition of TGF-β-induced EndoMT)

    高橋 和樹, 勝又 寿枝, 小林 美穂, 時崎 詩織, 池田 行徳, 前田 健太郎, 井上 カタジナアンナ, 松永 行子, 吉松 康裕, 渡部 徹郎

    日本癌学会総会記事   82回   466 - 466   2023.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • Roles of TGF-β signals in tumor microenvironment via regulation of the formation and plasticity of vascular system. International journal

    Tetsuro Watabe, Kazuki Takahashi, Kristian Pietras, Yasuhiro Yoshimatsu

    Seminars in cancer biology   92   130 - 138   2023.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Tumor cells evolve in tumor microenvironment composed of multiple cell types. Among these, endothelial cells (ECs) are the major players in tumor angiogenesis, which is a driver of tumor progression and metastasis. Increasing evidence suggests that ECs also contribute to tumor progression and metastasis as they modify their phenotypes to differentiate into mesenchymal cells through a process known as endothelial-mesenchymal transition (EndoMT). This plasticity of ECs is mediated by various cytokines, including transforming growth factor-β (TGF-β), and modulated by other stimuli depending on the cellular contexts. Recent lines of evidence have shown that EndoMT is involved in various steps of tumor progression, including tumor angiogenesis, intravasation and extravasation of cancer cells, formation of cancer-associated fibroblasts, and cancer therapy resistance. In this review, we summarize current updates on EndoMT, highlight the roles of EndoMT in tumor progression and metastasis, and underline targeting EndoMT as a potential therapeutic strategy.

    DOI: 10.1016/j.semcancer.2023.04.007

    PubMed

    researchmap

  • An analysis modality for vascular structures combining tissue-clearing technology and topological data analysis. International journal

    Kei Takahashi, Ko Abe, Shimpei I Kubota, Noriaki Fukatsu, Yasuyuki Morishita, Yasuhiro Yoshimatsu, Satoshi Hirakawa, Yoshiaki Kubota, Tetsuro Watabe, Shogo Ehata, Hiroki R Ueda, Teppei Shimamura, Kohei Miyazono

    Nature communications   13 ( 1 )   5239 - 5239   2022.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The blood and lymphatic vasculature networks are not yet fully understood even in mouse because of the inherent limitations of imaging systems and quantification methods. This study aims to evaluate the usefulness of the tissue-clearing technology for visualizing blood and lymphatic vessels in adult mouse. Clear, unobstructed brain/body imaging cocktails and computational analysis (CUBIC) enables us to capture the high-resolution 3D images of organ- or area-specific vascular structures. To evaluate these 3D structural images, signals are first classified from the original captured images by machine learning at pixel base. Then, these classified target signals are subjected to topological data analysis and non-homogeneous Poisson process model to extract geometric features. Consequently, the structural difference of vasculatures is successfully evaluated in mouse disease models. In conclusion, this study demonstrates the utility of CUBIC for analysis of vascular structures and presents its feasibility as an analysis modality in combination with 3D images and mathematical frameworks.

    DOI: 10.1038/s41467-022-32848-2

    PubMed

    researchmap

  • Correction to: Dose-response relationship of pulmonary disorders by inhalation exposure to cross-linked water-soluble acrylic acid polymers in F344 rats. International journal

    Tomoki Takeda, Shotaro Yamano, Yuko Goto, Shigeyuki Hirai, Yusuke Furukawa, Yoshinori Kikuchi, Kyohei Misumi, Masaaki Suzuki, Kenji Takanobu, Hideki Senoh, Misae Saito, Hitomi Kondo, George Daghlian, Young-Kwon Hong, Yasuhiro Yoshimatsu, Masanori Hirashima, Yoichiro Kobashi, Kenzo Okamoto, Takumi Kishimoto, Yumi Umeda

    Particle and fibre toxicology   19 ( 1 )   35 - 35   2022.5

     More details

    Language:English  

    [Image: see text]

    DOI: 10.1186/s12989-022-00475-w

    PubMed

    researchmap

  • Dose-response relationship of pulmonary disorders by inhalation exposure to cross-linked water-soluble acrylic acid polymers in F344 rats. International journal

    Tomoki Takeda, Shotaro Yamano, Yuko Goto, Shigeyuki Hirai, Yusuke Furukawa, Yoshinori Kikuchi, Kyohei Misumi, Masaaki Suzuki, Kenji Takanobu, Hideki Senoh, Misae Saito, Hitomi Kondo, George Daghlian, Young-Kwon Hong, Yasuhiro Yoshimatsu, Masanori Hirashima, Yoichiro Kobashi, Kenzo Okamoto, Takumi Kishimoto, Yumi Umeda

    Particle and fibre toxicology   19 ( 1 )   27 - 27   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: In Japan, six workers handling cross-linked water-soluble acrylic acid polymer (CWAAP) at a chemical plant suffered from lung diseases, including fibrosis, interstitial pneumonia, emphysema, and pneumothorax. We recently demonstrated that inhalation of CWAAP-A, one type of CWAAP, causes pulmonary disorders in rats. It is important to investigate dose-response relationships and recoverability from exposure to CWAAPs for establishing occupational health guidelines, such as setting threshold limit value for CWAAPs in the workplace. METHODS: Male and female F344 rats were exposed to 0.3, 1, 3, or 10 mg/m3 CWAAP-A for 6 h/day, 5 days/week for 13 weeks using a whole-body inhalation exposure system. At 1 h, 4 weeks, and 13 weeks after the last exposure the rats were euthanized and blood, bronchoalveolar lavage fluid, and all tissues including lungs and mediastinal lymph nodes were collected and subjected to biological and histopathological analyses. In a second experiment, male rats were pre-treated with clodronate liposome or polymorphonuclear leukocyte-neutralizing antibody to deplete macrophages or neutrophils, respectively, and exposed to CWAAP-A for 6 h/day for 2 days. RESULTS: CWAAP-A exposure damaged only the alveoli. The lowest observed adverse effect concentration (LOAEC) was 1 mg/m3 and the no observed adverse effect concentration (NOAEC) was 0.3 mg/m3. Rats of both sexes were able to recover from the tissue damage caused by 13 weeks exposure to 1 mg/m3 CWAAP-A. In contrast, tissue damage caused by exposure to 3 and 10 mg/m3 was irreversible due to the development of interstitial lung lesions. There was a gender difference in the recovery from CWAAP-A induced pulmonary disorders, with females recovering less than males. Finally, acute lung effects caused by CWAAP-A were significantly reduced by depletion of alveolar macrophages. CONCLUSIONS: Pulmonary damage caused by inhalation exposure to CWAAP-A was dose-dependent, specific to the lung and lymph nodes, and acute lung damage was ameliorated by depleting macrophages in the lungs. CWAAP-A had both a LOAEC and a NOAEC, and tissue damage caused by exposure to 1 mg/m3 CWAAP-A was reversible: recovery in female rats was less than for males. These findings indicate that concentration limits for CWAAPs in the workplace can be determined.

    DOI: 10.1186/s12989-022-00468-9

    PubMed

    researchmap

  • Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease. International journal

    Yasuhiro Yoshimatsu, Tetsuro Watabe

    Inflammation and regeneration   42 ( 1 )   9 - 9   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Endothelial-mesenchymal transition (EndoMT), a cellular differentiation process in which endothelial cells (ECs) lose their properties and differentiate into mesenchymal cells, has been observed not only during development but also in various pathological states in adults, including cancer progression and organ/tissue fibrosis. Transforming growth factor-β (TGF-β), an inflammation-related cytokine, has been shown to play central roles in the induction of EndoMT. TGF-β induces EndoMT by regulating the expression of various transcription factors, signaling molecules, and cellular components that confer ECs with mesenchymal characteristics. However, TGF-β by itself is not necessarily sufficient to induce EndoMT to promote the progression of EndoMT-related diseases to a refractory extent. In addition to TGF-β, additional activation by other inflammatory factors is often required to stabilize the progression of EndoMT. Since recent lines of evidence indicate that inflammatory signaling molecules act as enhancers of EndoMT, we summarize the roles of inflammatory factors in the induction of EndoMT and related diseases. We hope that this review will help to develop therapeutic strategies for EndoMT-related diseases by targeting inflammation-mediated EndoMT.

    DOI: 10.1186/s41232-021-00186-3

    PubMed

    researchmap

  • Construction of transplantable artificial vascular tissue based on adipose tissue-derived mesenchymal stromal cells by a cell coating and cryopreservation technique. International journal

    Yoshiya Asano, Daisuke Okano, Michiya Matsusaki, Tetsuro Watabe, Yasuhiro Yoshimatsu, Mitsuru Akashi, Hiroshi Shimoda

    Scientific reports   11 ( 1 )   17989 - 17989   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Prevascularized artificial three-dimensional (3D) tissues are effective biomaterials for regenerative medicine. We have previously established a scaffold-free 3D artificial vascular tissue from normal human dermal fibroblasts (NHDFs) and umbilical vein-derived endothelial cells (HUVECs) by layer-by-layer cell coating technique. In this study, we constructed an artificial vascular tissue constructed by human adipose tissue-derived stromal cells (hASCs) and HUVECs (ASCVT) by a modified technique with cryopreservation. ASCVT showed a higher thickness with more dense vascular networks than the 3D tissue based on NHDFs. Correspondingly, 3D-cultured ASCs showed higher expression of several angiogenesis-related factors, including vascular endothelial growth factor-A and hepatic growth factor, compared to that of NHDFs. Moreover, perivascular cells in ASCVT were detected by pericyte markers, suggesting the differentiation of hASCs into pericyte-like cells. Subcutaneous transplantation of ASCVTs to nude mice resulted in an engraftment with anastomosis of host's vascular structures at 2 weeks after operation. In the engrafted tissue, the vascular network was surrounded by mural-like structure-forming hASCs, in which some parts developed to form vein-like structures at 4 weeks, suggesting the generation of functional vessel networks. These results demonstrated that cryopreserved human cells, including hASCs, could be used directly to construct the artificial transplantable tissue for regenerative medicine.

    DOI: 10.1038/s41598-021-97547-2

    PubMed

    researchmap

  • 内皮間葉移行で促進される上皮間葉移行におけるETSファミリー転写因子の役割

    吉松 康裕, 前田 健太郎, 高橋 直也, 若林 育海, 紀室 志織, 高橋 和樹, 小林 美穂, 井上 カタジナアンナ, 平島 正則, 宮園 浩平, 渡部 徹郎

    日本癌学会総会記事   80回   [E11 - 5]   2021.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis. Reviewed International journal

    Koichi Nishino, Yasuhiro Yoshimatsu, Tomoki Muramatsu, Yasuhito Sekimoto, Keiko Mitani, Etsuko Kobayashi, Shouichi Okamoto, Hiroki Ebana, Yoshinori Okada, Masatoshi Kurihara, Kenji Suzuki, Johji Inazawa, Kazuhisa Takahashi, Tetsuro Watabe, Kuniaki Seyama

    Scientific reports   11 ( 1 )   8406 - 8406   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Lymphangioleiomyomatosis (LAM) is a rare pulmonary disease characterised by the proliferation of smooth muscle-like cells (LAM cells), and an abundance of lymphatic vessels in LAM lesions. Studies reported that vascular endothelial growth factor-D (VEGF-D) secreted by LAM cells contributes to LAM-associated lymphangiogenesis, however, the precise mechanisms of lymphangiogenesis and characteristics of lymphatic endothelial cells (LECs) in LAM lesions have not yet been elucidated. In this study, human primary-cultured LECs were obtained both from LAM-affected lung tissues (LAM-LECs) and normal lung tissues (control LECs) using fluorescence-activated cell sorting (FACS). We found that LAM-LECs had significantly higher ability of proliferation and migration compared to control LECs. VEGF-D significantly promoted migration of LECs but not proliferation of LECs in vitro. cDNA microarray and FACS analysis revealed the expression of vascular endothelial growth factor receptor (VEGFR)-3 and integrin α9 were elevated in LAM-LECs. Inhibition of VEGFR-3 suppressed proliferation and migration of LECs, and blockade of integrin α9 reduced VEGF-D-induced migration of LECs. Our data uncovered the distinct features of LAM-associated LECs, increased proliferation and migration, which may be due to higher expression of VEGFR-3 and integrin α9. Furthermore, we also found VEGF-D/VEGFR-3 and VEGF-D/ integrin α9 signaling play an important role in LAM-associated lymphangiogenesis.

    DOI: 10.1038/s41598-021-88064-3

    PubMed

    researchmap

  • ASK1 suppresses NK cell‐mediated intravascular tumor cell clearance in lung metastasis Reviewed

    Makoto Fujimoto, Miki Kamiyama, Kosuke Fuse, Hiroki Ryuno, Takeru Odawara, Natsuki Furukawa, Yasuhiro Yoshimatsu, Tetsuro Watabe, Michaela Prchal‐Murphy, Veronika Sexl, Hideaki Tahara, Yoshihiro Hayakawa, Takehiro Sato, Kohsuke Takeda, Isao Naguro, Hidenori Ichijo

    Cancer Science   112 ( 4 )   1633 - 1643   2021.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Tumor metastasis is the leading cause of death worldwide and involves an extremely complex process composed of multiple steps. Our previous study demonstrated that apoptosis signal-regulating kinase 1 (ASK1) deficiency in mice attenuates tumor metastasis in an experimental lung metastasis model. However, the steps of tumor metastasis regulated by ASK1 remain unclear. Here, we showed that ASK1 deficiency in mice promotes natural killer (NK) cell-mediated intravascular tumor cell clearance in the initial hours of metastasis. In response to tumor inoculation, ASK1 deficiency upregulated immune response-related genes, including interferon-gamma (IFNγ). We also revealed that NK cells are required for these anti-metastatic phenotypes. ASK1 deficiency augmented cytokine production chemoattractive to NK cells possibly through induction of the ligand for NKG2D, a key activating receptor of NK cells, leading to further recruitment of NK cells into the lung. These results indicate that ASK1 negatively regulates NK cell-dependent anti-tumor immunity and that ASK1-targeted therapy can provide a new tool for cancer immunotherapy to overcome tumor metastasis.

    DOI: 10.1111/cas.14842

    Scopus

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cas.14842

  • Targeting all transforming growth factor-β isoforms with a Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer Reviewed

    Takahashi K, Akatsu Y, Podyma-Inoue KA, Matsumoto T, Takahashi H, Yoshimatsu Y, Koinuma D, Shirouzu M, Miyazono K, Watabe T

    Journal of Biological Chemistry   2020.12

     More details

  • 内皮間葉移行によって活性化された内皮細胞由来のTGF-βシグナルは口腔がん細胞の上皮間葉移行を誘導する

    吉松 康裕, 若林 育海, 紀室 志織, 高橋 直也, 高橋 和樹, 小林 美穂, 井上 カタジナアンナ, 宮園 浩平, 渡部 徹郎

    日本癌学会総会記事   79回   OE13 - 1   2020.10

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • TGF-βによる血管内皮間葉移行の誘導におけるTNF-αの役割の検討

    若林 育海, 吉松 康裕, 紀室 志織, 高橋 直也, 高橋 和樹, 伊東 史子, 小林 美穂, 井上 カタジナアンナ, 宮園 浩平, 渡部 徹郎

    日本生化学会大会プログラム・講演要旨集   93回   [P - 756]   2020.9

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation Reviewed

    Yasuhiro Yoshimatsu, Ikumi Wakabayashi, Shiori Kimuro, Naoya Takahashi, Kazuki Takahashi, Miho Kobayashi, Nako Maishi, Katarzyna A. Podyma‐Inoue, Kyoko Hida, Kohei Miyazono, Tetsuro Watabe

    Cancer Science   111 ( 7 )   2385 - 2399   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/cas.14455

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cas.14455

  • Peptide‐2 from mouse myostatin precursor protein alleviates muscle wasting in cancer‐associated cachexia Reviewed

    Ojima C, Noguchi Y, Miyamoto T, Saito Y, Orihashi H, Yoshimatsu Y, Watabe T, Takayama K, Hayashi Y, Itoh F

    Cancer Science   2020.6

     More details

  • TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of Activin signals Reviewed

    Yasuhiro Yoshimatsu, Shiori Kimuro, Joris Pauty, Kazuki Takagaki, Sanae Nomiyama, Akihiko Inagawa, Kentaro Maeda, Katarzyna A. Podyma-Inoue, Kentaro Kajiya, Yukiko T. Matsunaga, Tetsuro Watabe

    PLOS ONE   15 ( 5 )   2020.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Lymphatic systems play important roles in the maintenance of fluid homeostasis and undergo anatomical and physiological changes during inflammation and aging. While lymphatic endothelial cells (LECs) undergo mesenchymal transition in response to transforming growth factor-beta (TGF-beta), the molecular mechanisms underlying endothelial-to-mesenchymal transition (EndMT) of LECs remain largely unknown. In this study, we examined the effect of TGF-beta 2 and tumor necrosis factor-alpha (TNF-alpha), an inflammatory cytokine, on EndMT using human skin-derived lymphatic endothelial cells (HDLECs). TGF-beta 2-treated HDLECs showed increased expression of SM22 alpha, a mesenchymal cell marker accompanied by increased cell motility and vascular permeability, suggesting HDLECs to undergo EndMT. Our data also revealed that TNF-alpha could enhance TGF-beta 2-induced EndMT of HDLECs. Furthermore, both cytokines induced the production of Activin A while decreasing the expression of its inhibitory molecule Follistatin, and thus enhancing EndMT. Finally, we demonstrated that human dermal lymphatic vessels underwent EndMT during aging, characterized by double immunostaining for LYVE1 and SM22 alpha. These results suggest that both TGF-beta and TNF-alpha signals play a central role in EndMT of LECs and could be potential targets for senile edema.

    DOI: 10.1371/journal.pone.0232356

    Web of Science

    researchmap

  • 線維芽細胞増殖因子(FGF2)は腫瘍血管内皮細胞においてTGF-βによって誘導される内皮-筋線維芽移行を制御する(Fibroblast growth factor 2 regulates TGF-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells)

    吉松 康裕, 赤津 裕一, 高橋 直也, 紀室 志織, 村松 智輝, 桂 彰宏, 間石 奈湖, 鈴木 洋, 稲澤 譲治, 樋田 京子, 宮園 浩平, 渡部 徹郎

    日本癌学会総会記事   78回   P - 2280   2019.9

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1 Reviewed

    *Akatsu Y, *Takahashi N, *Yoshimatsu Y, Kimuro S, Muramatsu T, Katsura A, Maishi N, Suzuki HI, Inazawa J, Hida K, Miyazono K, Watabe T, ual contribution

    Molecular Oncology   2019.5

     More details

    Authorship:Lead author  

    researchmap

  • Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma Reviewed

    Okamoto H, Yoshimatsu Y, Tomizawa T, Kunita A, Takayama A, Morikawa T, Komura D, Takahashi K, Oshima T, Sato M, Komai M, Podyma-Inoue KA, Uchida H, Hamada H, Fujiu K, Ishikawa S, Fukayama M, Fukuhara T, Watabe T

    Scientific Reports   9 ( 1281 )   2019.1

     More details

    Authorship:Lead author  

    researchmap

  • Regulatory role of transforming growth factor-β signals in the migration and tumor formation of HOC313-LM cells, an oral squamous cell carcinoma Reviewed

    Takahashi K, Podyma-Inoue KA, Takao C, Yoshimatsu Y, Muramatsu T, Inazawa J, Watabe T

    The Journal of the Stomatological Society   85 ( 2 )   52 - 61   2018

     More details

    Language:English   Publisher:口腔病学会  

    強い浸潤能を示す口腔扁平上皮癌(OSCC)細胞株のHOC313-LM細胞を用いて、その増殖、遊走、腫瘍形成においてトランスフォーミング増殖因子(TGF)-βシグナル伝達経路やRhoシグナル伝達経路が果たす役割について検討した。他の種類の上皮性癌細胞とは異なり、HOC313-LM細胞株の増殖はTGF-βやTGF-β受容体I型阻害剤による影響を受けなかった。しかしTGF-βシグナルは同細胞株の運動性を亢進させた。その亢進作用はRhoシグナルに依存していることが明らかにされ、ROCK阻害剤によりその作用が打ち消された。また、TGF-β受容体II型の変異型を発現させたマウスにHOC313-LM細胞株を皮下異種移植したモデルを用い、腫瘍成長におけるTGF-βシグナルの役割をin vivoで検証する実験を行った。その結果、TGF-βシグナル伝達が阻害されることで腫瘍成長は促進されることが示され、その促進はおそらく血管新生が刺激されたことによるものと考えられた。口腔癌進行に監視TGF-βシグナル伝達とRhoシグナル伝達が関与していることが示唆された。

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2018&ichushi_jid=J00443&link_issn=&doc_id=20180809300002&doc_link_id=%2Fee3kouku%2F2018%2F008502%2F002%2F0052-0061%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fee3kouku%2F2018%2F008502%2F002%2F0052-0061%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • Dual targeting of vascular endothelial growth factor and bone morphogenetic protein-9/10 impairs tumor growth through inhibition of angiogenesis Reviewed

    Yuichi Akatsu, Yasuhiro Yoshimatsu, Taishi Tomizawa, Kazuki Takahashi, Akihiro Katsura, Kohei Miyazono, Tetsuro Watabe

    CANCER SCIENCE   108 ( 1 )   151 - 155   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Clinical development of anti-angiogenic agents has been a major landmark in cancer therapy for several types of cancers. Signals mediated by both vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP)-9 and 10 have been implicated in tumor angiogenesis. However, previous studies have shown that targeting the individual signals was not sufficiently effective in retarding tumor growth in certain preclinical and clinical conditions. In the present study, we developed a novel decoy chimeric receptor that traps both VEGF and BMP-9/10. Single targeting of either VEGF or BMP-9/10 signals significantly reduced the formation of tumor vessels in a mouse xenograft model of human pancreatic cancer; however, it did not show significant therapeutic effects on tumor growth. In contrast, dual targeting of the angiogenic signals resulted in more significant inhibition of tumor angiogenesis, leading to delay of tumor growth. Our findings suggest that simultaneous blockade of VEGF and BMP-9/10 signals is a promising therapeutic strategy for the cancers that are resistant to anti-VEGF and BMP-9/10 therapies.

    DOI: 10.1111/cas.13103

    Web of Science

    PubMed

    researchmap

  • Roles of signaling and transcriptional networks in pathological lymphangiogenesis Reviewed

    Yasuhiro Yoshimatsu, Hideki Miyazaki, Tetsuro Watabe

    ADVANCED DRUG DELIVERY REVIEWS   99 ( Pt B )   161 - 171   2016.4

     More details

    Authorship:Lead author   Language:English   Publisher:ELSEVIER SCIENCE BV  

    Lymphangiogenesis, the generation of new lymphatic vessels, plays important roles in cancer metastasis. Outstanding progress during the past decade has dramatically increased the novel knowledge and insights of the mechanisms underlying the generation of new lymphatic vessels, the roles of transcription factors and lymphangiogenic growth factors during physiological development and pathological processes such as cancer and inflammation. Furthermore, an understanding of the molecular consequences during tumor lymphangiogenesis has provided chances to develop better diagnostic and therapeutic approaches that aim to limit the progression of cancer. In this article, we will explain the current knowledge of how lymphatic function is altered in various pathological conditions including cancer progression. (C) 2016 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.addr.2016.01.020

    Web of Science

    PubMed

    researchmap

  • Expression of platelet-derived growth factor receptor beta is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis Reviewed

    Hideki Miyazaki, Yasuhiro Yoshimatsu, Yuichi Akatsu, Koichi Mishima, Masashi Fukayama, Tetsuro Watabe, Kohei Miyazono

    CANCER SCIENCE   105 ( 9 )   1116 - 1123   2014.9

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    The lymphatic system plays important roles not only in the physiological processes, such as maintenance of tissue fluid homeostasis, but also in pathological processes including the lymph node metastasis of tumor cells. Therefore, understanding of the molecular mechanisms underlying lymphatic vessel formation is crucial. Previous studies have shown that proliferation and migration of lymphatic endothelial cells (LECs) are activated by multiple types of signals mediated by tyrosine kinase receptors such as vascular endothelial growth factor receptor (VEGFR) 3. Although signals mediated by platelet-derived growth factor receptor (PDGFR) have been implicated in lymphangiogenesis, the mechanisms explaining how PDGFR expression is maintained in LECs remain to be fully elucidated. In the present study, we show that PDGFR expression in LECs is maintained by Prox1 transcription factor. Knockdown of Prox1 expression in human dermal LECs decreased the expression of PDGFR, leading to the lowered migration of human dermal LECs towards PDGF-BB. Furthermore, we found that PDGF signals play important roles in inflammatory lymphangiogenesis in a chronic aseptic peritonitis model. Intraperitoneal administration of imatinib, a potent inhibitor of PDGFR, and transduction of PDGFR/Fc chimeric protein by an adenoviral system both reduced inflammatory lymphangiogenesis induced by thioglycollate in mice. We also found that the expression of PDGFR/Fc reduced tumor lymphangiogenesis in a BxPC3 human pancreatic cancer xenograft model. These findings suggest that PDGFR is one of the key mediators of lymphatic vessel formation acting downstream of Prox1.

    DOI: 10.1111/cas.12476

    Web of Science

    PubMed

    researchmap

  • Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression Reviewed

    Yasuhiro Yoshimatsu, Yulia G. Lee, Yuichi Akatsu, Luna Taguchi, Hiroshi I. Suzuki, Sara I. Cunha, Kazuichi Maruyama, Yuka Suzuki, Tomoko Yamazaki, Akihiro Katsura, S. Paul Oh, Teresa A. Zimmers, Se-Jin Lee, Kristian Pietras, Gou Young Koh, Kohei Miyazono, Tetsuro Watabe

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   110 ( 47 )   18940 - 18945   2013.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    Lymphatic vessels (LVs) play critical roles in the maintenance of fluid homeostasis and in pathological conditions, including cancer metastasis. Although mutations in ALK1, a member of the transforming growth factor (TGF)-beta/bone morphogenetic protein (BMP) receptor family, have been linked to hereditary hemorrhagic telangiectasia, a human vascular disease, the roles of activin receptor-like kinase 1(ALK-1) signals in LV formation largely remain to be elucidated. We show that ALK-1 signals inhibit LV formation, and LVs were enlarged in multiple organs in Alk1-depleted mice. These inhibitory effects of ALK-1 signaling were mediated by BMP-9, which decreased the number of cultured lymphatic endothelial cells. Bmp9-deficient mouse embryos consistently exhibited enlarged dermal LVs. BMP-9 also inhibited LV formation during inflammation and tumorigenesis. BMP-9 downregulated the expression of the transcription factor prospero-related homeobox 1, which is necessary to maintain lymphatic endothelial cell identity. Furthermore, silencing prospero-related homeobox 1 expression inhibited lymphatic endothelial cell proliferation. Our findings reveal a unique molecular basis for the physiological and pathological roles of BMP-9/ALK-1 signals in LV formation.

    DOI: 10.1073/pnas.1310479110

    Web of Science

    PubMed

    researchmap

  • TGF-beta-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A Reviewed

    Hajime Mihira, Hiroshi I. Suzuki, Yuichi Akatsu, Yasuhiro Yoshimatsu, Takashi Igarashi, Kohei Miyazono, Tetsuro Watabe

    JOURNAL OF BIOCHEMISTRY   151 ( 2 )   145 - 156   2012.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Endothelial-mesenchymal transition (EndMT) plays important roles in various physiological and pathological processes. While signals mediated by transforming growth factor (TGF)-beta have been implicated in EndMT, the molecular mechanisms underlying it remain to be fully elucidated. Here, we examined the effects of TGF-beta signals on the EndMT of mouse pancreatic microvascular endothelial cells (MS-1). By addition of TGF-beta 2, MS-1 cells underwent mesenchymal transition characterized by re-organization of actin stress fibre and increased expression of various mesenchymal markers such as alpha-smooth muscle actin (alpha-SMA) through activation of Rho signals. Whereas activation of Rho signals via TGF-beta-induced non-Smad signals has been implicated in epithelial-mesenchymal transition (EMT), we found that Arhgef5, a guanine nucleotide exchange factor, is induced by Smad signals and contributes to the TGF-beta 2-induced alpha-SMA expression in MS-1 cells. We also found that TGF-beta 2 induces the expression of myocardin-related transcription factor-A (MRTF-A) in a Smad-dependent fashion and its nuclear accumulation in MS-1 cells and that MRTF-A is required and sufficient for TGF-beta 2-induced alpha-SMA expression. These results indicate that activation of Smad signals by TGF-beta 2 have dual effects on the activation of Rho signals and MRTF-A leading to the mesenchymal transition of MS-1 endothelial cells.

    DOI: 10.1093/jb/mvr121

    Web of Science

    PubMed

    researchmap

  • Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1 Reviewed

    Yasuhiro Yoshimatsu, Tomoko Yamazaki, Hajime Mihira, Taichi Itoh, Junichi Suehiro, Keiko Yuki, Kaori Harada, Masato Morikawa, Caname Iwata, Takashi Minami, Yasuyuki Morishita, Tatsuhiko Kodama, Kohei Miyazono, Tetsuro Watabe

    JOURNAL OF CELL SCIENCE   124 ( 16 )   2753 - 2762   2011.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:COMPANY OF BIOLOGISTS LTD  

    Prox1 plays pivotal roles during embryonic lymphatic development and maintenance of adult lymphatic systems by modulating the expression of various lymphatic endothelial cell (LEC) markers, such as vascular endothelial growth factor receptor 3 (VEGFR3). However, the molecular mechanisms by which Prox1 transactivates its target genes remain largely unknown. Here, we identified Ets-2 as a candidate molecule that regulates the functions of Prox1. Whereas Ets-2 has been implicated in angiogenesis, its roles during lymphangiogenesis have not yet been elucidated. We found that endogenous Ets-2 interacts with Prox1 in LECs. Using an in vivo model of chronic aseptic peritonitis, we found that Ets-2 enhanced inflammatory lymphangiogenesis, whereas a dominant-negative mutant of Ets-1 suppressed it. Ets-2 also enhanced endothelial migration towards VEGF-C through induction of expression of VEGFR3 in collaboration with Prox1. Furthermore, we found that both Prox1 and Ets-2 bind to the VEGFR3 promoter in intact chromatin. These findings suggest that Ets family members function as transcriptional cofactors that enhance Prox1-induced lymphangiogenesis.

    DOI: 10.1242/jcs.083998

    Web of Science

    PubMed

    researchmap

  • Roles of TGF-β signals in endothelial-mesenchymal transition during cardiac fibrosis. Reviewed

    Yoshimatsu Y, Watabe T

    International journal of inflammation   2011   724080   2011

     More details

    Authorship:Lead author  

    DOI: 10.4061/2011/724080

    PubMed

    researchmap

  • Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis. International journal

    Kaori Harada, Tomoko Yamazaki, Caname Iwata, Yasuhiro Yoshimatsu, Hitoshi Sase, Koichi Mishima, Yasuyuki Morishita, Masanori Hirashima, Yuichi Oike, Toshio Suda, Naoyuki Miura, Tetsuro Watabe, Kohei Miyazono

    Journal of cell science   122 ( Pt 21 )   3923 - 30   2009.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    During lymphatic development, Prox1 plays central roles in the differentiation of blood vascular endothelial cells (BECs) into lymphatic endothelial cells (LECs), and subsequently in the maturation and maintenance of lymphatic vessels. However, the molecular mechanisms by which Prox1 elicits these functions remain to be elucidated. Here, we identified FoxC2 and angiopoietin-2 (Ang2), which play important roles in the maturation of lymphatic vessels, as novel targets of Prox1 in mouse embryonic-stem-cell-derived endothelial cells (MESECs). Furthermore, we found that expression of HoxD8 was significantly induced by Prox1 in MESECs, a finding confirmed in human umbilical vein endothelial cells (HUVECs) and human dermal LECs (HDLECs). In mouse embryos, HoxD8 expression was significantly higher in LECs than in BECs. In a model of inflammatory lymphangiogenesis, diameters of lymphatic vessels of the diaphragm were increased by adenovirally transduced HoxD8. We also found that HoxD8 induces Ang2 expression in HDLECs and HUVECs. Moreover, we found that HoxD8 induces Prox1 expression in HUVECs and that knockdown of HoxD8 reduces this expression in HDLECs, suggesting that Prox1 expression in LECs is maintained by HoxD8. These findings indicate that transcriptional networks of Prox1 and HoxD8 play important roles in the maturation and maintenance of lymphatic vessels.

    DOI: 10.1242/jcs.052324

    PubMed

    researchmap

  • COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. International journal

    Tomoko Yamazaki, Yasuhiro Yoshimatsu, Yasuyuki Morishita, Kohei Miyazono, Tetsuro Watabe

    Genes to cells : devoted to molecular & cellular mechanisms   14 ( 3 )   425 - 34   2009.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    During embryonic lymphatic development, Prox1 homeobox transcription factor is expressed in a subset of venous blood vascular endothelial cells (BECs) in which COUP-TFII orphan nuclear receptor is highly expressed. Prox1 induces differentiation of BECs into lymphatic endothelial cells (LECs) by inducing the expression of various LEC markers including vascular endothelial growth factor receptor 3 (VEGFR3). However, the molecular mechanisms of how transcriptional activities of Prox1 are regulated are largely unknown. In the present study, we show that COUP-TFII plays important roles in the regulation of the function of Prox1. In BECs and LECs, Prox1 promotes the proliferation and migration toward VEGF-C by inducing the expression of cyclin E1 and VEGFR3, respectively. Gain-of-function studies showed that COUP-TFII negatively regulates the effects of Prox1 in BECs and LECs whereas loss-of-function studies showed that COUP-TFII negatively and positively regulates Prox1 in BECs and LECs, respectively. We also show that endogenous Prox1 and COUP-TFII physically interact in LECs and that both Prox1 and COUP-TFII bind to the endogenous cyclin E1 promoter. These results suggest that COUP-TFII physically and functionally interact during differentiation and maintenance of lymphatic vessels.

    DOI: 10.1111/j.1365-2443.2008.01279.x

    PubMed

    researchmap

  • Prox1 induces lymphatic endothelial differentiation via integrin alpha 9 and other signaling cascades Reviewed

    Koichi Mishima, Tetsuro Watabe, Akira Saito, Yasuhiro Yoshimatsu, Natsuko Imaizumi, Shinji Masui, Masanori Hirashima, Tohru Morisada, Yuichi Oike, Makoto Araie, Hitoshi Niwa, Hajime Kubo, Toshio Suda, Kohei Miyazono

    MOLECULAR BIOLOGY OF THE CELL   18 ( 4 )   1421 - 1429   2007.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC CELL BIOLOGY  

    During embryonic lymphatic development, a homeobox transcription factor Prox1 plays important roles in sprouting and migration of a subpopulation of blood vessel endothelial cells (BECs) toward VEGF-C-expressing cells. However, effects of Prox1 on endothelial cellular behavior remain to be elucidated. Here, we show that Prox1, via induction of integrin alpha 9 expression, inhibits sheet formation and stimulates motility of endothelial cells. Prox1-expressing BECs preferentially migrated toward VEGF-C via up-regulation of the expression of integrin a9 and VEGF receptor 3 (VEGFR3). In mouse embryos, expression of VEGFR3 and integrin a9 is increased in Prox1-expressing lymphatic endothelial cells (LECs) compared with BECs. Knockdown of Prox1 expression in human LECs led to decrease in the expression of integrin a9 and VEGFR3, resulting in the decreased chemotaxes toward VEGF-C. These findings suggest that Prox1 plays important roles in conferring and maintaining the characteristics of LECs by modulating multiple signaling cascades and that integrin a9 may function as a key regulator of lymphangiogenesis acting downstream of Prox1.

    DOI: 10.1091/mbc.E06-09-0780

    Web of Science

    PubMed

    researchmap

  • Smad7-induced beta-catenin degradation alters epidermal appendage development. International journal

    Gangwen Han, Allen G Li, Yao-Yun Liang, Philip Owens, Wei He, Shilong Lu, Yasuhiro Yoshimatsu, Donna Wang, Peter Ten Dijke, Xia Lin, Xiao-Jing Wang

    Developmental cell   11 ( 3 )   301 - 12   2006.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    To assess whether Smad signaling affects skin development, we generated transgenic mice in which a Smad antagonist, Smad7, was induced in keratinocytes, including epidermal stem cells. Smad7 transgene induction perturbed hair follicle morphogenesis and differentiation, but accelerated sebaceous gland morphogenesis. Further analysis revealed that independent of its role in anti-Smad signaling, Smad7 bound beta-catenin and induced beta-catenin degradation by recruiting an E3 ligase, Smurf2, to the Smad7/beta-catenin complex. Consequently, Wnt/beta-catenin signaling was suppressed in Smad7 transgenic hair follicles. Coexpression of the Smurf2 and Smad7 transgenes exacerbated Smad7-induced abnormalities in hair follicles and sebaceous glands. Conversely, when endogenous Smad7 was knocked down, keratinocytes exhibited increased beta-catenin protein and enhanced Wnt signaling. Our data reveal a mechanism for Smad7 in antagonizing Wnt/beta-catenin signaling, thereby shifting the skin differentiation program from forming hair follicles to sebaceous glands.

    PubMed

    researchmap

  • Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. International journal

    Qinghong Zhang, Yasuhiro Yoshimatsu, Jeffrey Hildebrand, Steven M Frisch, Richard H Goodman

    Cell   115 ( 2 )   177 - 86   2003.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Genetic knockout of the transcriptional corepressor CtBP in mouse embryo fibroblasts upregulates several genes involved in apoptosis. We predicted, therefore, that a propensity toward apoptosis might be regulated through changes in cellular CtBP. To identify pathways involved in this regulation, we screened a mouse embryo cDNA library with an E1A-CtBP complex and identified the homeodomain interacting protein kinase 2 (HIPK2), which had previously been linked to UV-directed apoptosis through its ability to phosphorylate p53. Expression of HIPK2 or exposure to UV irradiation reduced CtBP levels via a proteosome-mediated pathway. The UV effect was prevented by coexpression of kinase-inactive HIPK2 or reduction in HIPK2 levels via siRNA. Mutation of the residue phosphorylated by HIPK2 prevented UV- and HIPK2-directed CtBP clearance. Finally, reduction in CtBP levels, either by genetic knockout or siRNA, promoted apoptosis in p53-deficient cells. These findings provide a pathway for UV-induced apoptosis in cells lacking p53.

    PubMed

    researchmap

  • In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. International journal

    Akihisa Matsuyama, Tadahiro Shimazu, Yuko Sumida, Akiko Saito, Yasuhiro Yoshimatsu, Daphné Seigneurin-Berny, Hiroyuki Osada, Yasuhiko Komatsu, Norikazu Nishino, Saadi Khochbin, Sueharu Horinouchi, Minoru Yoshida

    The EMBO journal   21 ( 24 )   6820 - 31   2002.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Trichostatin A (TSA) inhibits all histone deacetylases (HDACs) of both class I and II, whereas trapoxin (TPX) cannot inhibit HDAC6, a cytoplasmic member of class II HDACs. We took advantage of this differential sensitivity of HDAC6 to TSA and TPX to identify its substrates. Using this approach, alpha-tubulin was identified as an HDAC6 substrate. HDAC6 deacetylated alpha-tubulin both in vivo and in vitro. Our investigations suggest that HDAC6 controls the stability of a dynamic pool of microtubules. Indeed, we found that highly acetylated microtubules observed after TSA treatment exhibited delayed drug-induced depolymerization and that HDAC6 overexpression prompted their induced depolymerization. Depolymerized tubulin was rapidly deacetylated in vivo, whereas tubulin acetylation occurred only after polymerization. We therefore suggest that acetylation and deacetylation are coupled to the microtubule turnover and that HDAC6 plays a key regulatory role in the stability of the dynamic microtubules.

    PubMed

    researchmap

▶ display all

MISC

  • Endothelial mesenchymal transition (EndoMT) reporter cells visualized stepwise transition of TGF-β-induced EndoMT

    高橋和樹, 勝又寿枝, 小林美穂, 時崎詩織, 時崎詩織, 池田行徳, 前田健太郎, 井上カタジナアンナ, 松永行子, 吉松康裕, 吉松康裕, 渡部徹郎, 渡部徹郎

    日本癌学会学術総会抄録集(Web)   82nd   2023

  • 内皮間葉移行(EndoMT)レポーター内皮細胞を用いたEndoMT遷移段階の可視化

    高橋和樹, 高橋和樹, 勝又寿枝, 小林美穂, 前田健太郎, 吉松康裕, 吉松康裕, 松永行子, 渡部徹郎, 渡部徹郎

    リンパ学   46 ( Supplement )   2023

  • Oral cancer cells under TGF-beta-induced cell cycle arrest exhibit motile phenotypes through induction of EMT

    Kazuki Takahashi, Katarzyna A. Inoue, Shintaro Sakakitani, Toru Konisi, Akinari Sugauchi, Maki Saito, Atsushi Kaida, Daizo Koinuma, Yasuhiro Yoshimatsu, Toshihiro Uchihashi, Mikihiko Kogo, Masahiko Miura, Kohei Miyazono, Tetsuro Watabe

    CANCER SCIENCE   113   910 - 910   2022.2

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY  

    Web of Science

    researchmap

  • Visualization of endothelial-mesenchymal transition (EndoMT) and intravasation of cancer cells using EndoMT reporter cells

    高橋和樹, 高橋和樹, 勝又寿枝, 小林美穂, 池田行徳, 篠原満利恵, 前田健太郎, 吉松康裕, 吉松康裕, 松永行子, 渡部徹郎

    リンパ学   45 ( Supplement )   2022

  • 内皮間葉移行レポーター内皮細胞を用いた内皮間葉移行の遷移段階の可視化

    高橋和樹, 高橋和樹, 小林美穂, 勝又寿枝, 前田健太郎, 吉松康裕, 松永行子, 渡部徹郎

    日本血管生物医学会学術集会プログラム・抄録集   30th (CD-ROM)   2022

  • Relationship between vascular homeostasis and aging

    小林美穂, 小林美穂, 高橋和樹, 高橋和樹, 勝又寿枝, 廣瀬穂香, 吉松康裕, 中山雅敬, 松永行子, 渡部徹郎

    日本分子生物学会年会プログラム・要旨集(Web)   45th   2022

  • Analysis of various stages during endothelial-mesenchymal transition (EndoMT) using EndoMT reporter cells

    勝又寿枝, 高橋和樹, 高橋和樹, 小林美穂, 前田健太郎, 紀室志織, 松永行子, 吉松康裕, 吉松康裕, 渡部徹郎

    リンパ学   45 ( Supplement )   2022

  • TGF-beta-induced cell cycle arrest is associated with increased migration and metastasis of oral squamous carcinoma cells

    Kazuki Takahashi, Katarzyna A. Inoue, Atsushi Kaida, Akinari Sugauchi, Toshihiro Uchihashi, Yasuhiro Yoshimatsu, Susumu Tanaka, Masahiko Miura, Mikihiko Kogo, Tetsuro Watabe

    CANCER SCIENCE   112   418 - 418   2021.2

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY  

    Web of Science

    researchmap

  • 内皮間葉移行で促進される上皮間葉移行におけるETSファミリー転写因子の役割

    吉松康裕, 吉松康裕, 前田健太郎, 高橋直也, 若林育海, 紀室志織, 高橋和樹, 高橋和樹, 小林美穂, 井上カタジナアンナ, 平島正則, 宮園浩平, 渡部徹郎

    日本癌学会学術総会抄録集(Web)   80th   2021

  • 全てのTGF-βアイソフォームを標的としたFc融合タンパク質は口腔扁平上皮がん細胞において腫瘍形成と血管新生を阻害する

    高橋瞳, 高橋和樹, 赤津裕一, 赤津裕一, PODYMA-INOUE Katarzyna A., 松本武久, 吉松康裕, 吉松康裕, 鯉沼代造, 白水美香子, 宮園浩平, 渡部徹郎

    日本分子生物学会年会プログラム・要旨集(Web)   43rd   2020

  • 悪性黒色腫の血管新生及び腫瘍形成能におけるIL13Rα2の役割

    高山莉那, 岡本勇人, 吉松康裕, 富澤泰志, 国田朱子, 高橋和樹, 井上カタジナアンナ, 深山正久, 福原武志, 渡部徹郎

    日本心血管内分泌代謝学会学術総会プログラム及び抄録集   23rd   2019

  • 口腔扁平上皮がん細胞HOC313-LMの運動能と腫瘍形成能の制御におけるトランスフォーミング増殖因子βシグナルの役割(Regulatory Role of Transforming Growth Factor-β Signals in the Migration and Tumor Formation of HOC313-LM cells, an Oral Squamous Cell Carcinoma)

    高橋 和樹, 井上 ポディマ, カタジナ アンナ, 高尾 千紘, 吉松 康裕, 村松 智輝, 稲澤 譲治, 渡部 徹郎

    口腔病学会雑誌   85 ( 2 )   52 - 61   2018.7

     More details

    Language:English   Publisher:口腔病学会  

    researchmap

  • 悪性黒色腫の進展に伴う腫瘍血管新生におけるインターロイキン13受容体の役割

    富澤泰志, 岡本勇人, 佐藤萌希, 駒井真央, 吉松康裕, 福原武志, 原田浩徳, 渡部徹郎

    日本分子生物学会年会プログラム・要旨集(Web)   39th   2016

  • Etsファミリー転写因子の血管・リンパ管内皮細胞における役割

    吉松康裕, 前田健太郎, 岩田要, 宮園浩平, 渡部徹郎

    リンパ学   38 ( Supplement )   2015

  • 悪性黒色腫の進展に伴う腫瘍血管新生におけるIL13Rα2の役割

    富澤泰志, 岡本勇人, 駒井真央, 佐藤萌希, 吉松康裕, 福原武志, 渡部徹郎

    日本血管生物医学会学術集会プログラム・抄録集   23rd   2015

  • Ets-2転写因子は内皮間葉移行(EndMT)を抑制する

    前田健太郎, 吉松康裕, 福原武志, 渡部徹郎

    日本血管生物医学会学術集会プログラム・抄録集   23rd   2015

  • Roles of TGF-beta superfamily in the lymphatic vessel formation

    63 ( 6 )   572 - 576   2012.11

  • Prox1結合因子であるEts‐2のリンパ管新生における役割

    吉松康裕, 三平元, 森川真人, 山崎智子, 岩田要, 森下保幸, 南敬, 児玉龍彦, 宮園浩平, 渡部徹郎

    日本血管生物医学会   17th   59   2009

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Prox1結合因子であるEts-2のリンパ管新生における役割

    吉松康裕, 三平元, 森川真人, 山崎智子, 岩田要, 森下保幸, 南敬, 児玉龍彦, 宮園浩平, 渡部徹郎

    日本血管生物医学会   17th   2009

▶ display all

Awards

  • The Young Investigator Awards of the Japanese Society of Lymphology

    2018.6   The Japanese Society of Lymphology  

    YOSHIMATSU YASUHIRO

     More details

  • The Young Investigator Awards of the Japanese Cancer Association

    2014.9   Japanese Cancer Association  

    YOSHIMATSU YASUHIRO

     More details

  • The Young Investigator Awards of the Japanese Vascular Biology and Medicine Organization

    2013.9   The Japanese Vascular Biology and Medicine Organization  

    YOSHIMATSU YASUHIRO

     More details

Research Projects

  • Roles of endothelial-mesenchymal transition (EndoMT)-suppressing transcription factors in the inhibition of cancer progression

    Grant number:21K07094

    2021.4 - 2024.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    researchmap